As per one of our previous articles, 1 in 9 Singaporeans suffer from diabetes and according to the World Health Organisation, the prevalence of diabetes among adults over 18 years old has risen from 4.7% in 1980 to 8.5% in 2014. Moreover, there has been a 5% increase in premature mortality from diabetes between 2000 and 2016. In Japan, approximately 13.5% of their population are affected by Type 2 diabetes or impaired glucose tolerance, which is why the disease was identified as a healthcare priority by the Ministry of Health, Labour and Welfare.
Quantum Operation Inc, a healthcare tech start-up in Japan launched in 2017, has developed the world’s first glucose measuring wristband that enables the wearer to monitor their blood glucose without having to stick needles everyday. The company’s patented patented spectrum sensing technology enables the sensor to accurately measure glucose in a person’s bloodstream and therefore, eliminates the need and pain of daily pricking for diabetic patients.
The device is easy to wear and connects to their app and as per Quantum Operation, it can also read other vital signs such as heart rate and ECG. All the user has to do is to slide the watch on and activate the monitoring from the menu.
Currently, the company is in the first state of seeking certification for commercial use of the wearable device.
To find out more about Quantum Operation and their devices, please visit their website at https://quantum-op.co.jp/en
Image: Quantum Operation Inc
Melissa Fann
Trevor Klass
Guest Contributor
